Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar mtprx (51.02) Submitted: 12/15/2006 8:44:39 PM : Outperform Start Price: $35.02 MRK Score: +8.87

Another vioxx case won by Merck. The company also recently introduced a new drug that can benefit patients who currently have to inject themselves with insulin on a daily basis. This is good news for those who don't appreciate the daily stick and for Merck who is first to market.

Featured Broker Partners


Advertisement